Philips CPAP Recall Settlement: $1.1B Payout Guide 2026

In June 2021, Philips Respironics issued a Class I recall—the FDA’s most serious designation—for approximately 15 million CPAP, BiPAP, and ventilator devices.

The culprit was polyester-based polyurethane (PE-PUR) sound abatement foam that degraded into toxic particles and volatile organic compounds users inhaled while sleeping.

If you or someone you love used a Philips CPAP machine manufactured between 2008 and 2021, this recall and the subsequent $1.1 billion settlement directly affect you.

Unsealed court documents suggest Philips knew about the foam degradation risks as early as 2015—six years before warning the public—making this not just a product failure, but a betrayal of trust for millions who depended on these devices to breathe safely at night.

What Happened: The Philips CPAP Recall Explained

The Philips CPAP recall represents one of the largest medical device failures in U.S. history. In June 2021, Philips issued a Class I recall for CPAP, BiPAP, and ventilator devices manufactured between 2008 and 2021.

The root cause was PE-PUR sound abatement foam used to dampen machine noise, which broke down into black debris and released volatile organic compounds that users inhaled during sleep.

According to unsealed court documents, Philips may have known about foam degradation risks as early as 2015.

Internal testing allegedly showed the foam was toxic and potentially carcinogenic, yet the company continued selling devices for six more years before issuing a public recall. This timeline forms the backbone of legal arguments claiming Philips failed to warn consumers about known dangers.

The degradation accelerated under specific conditions:

• Heat and humidity exposure during normal use

• Unapproved ozone-based cleaning methods (like SoClean devices)

• Extended periods of continuous operation

• Environmental factors in the user’s bedroom

Users who cleaned their machines with ozone cleaners faced even higher exposure risks to toxic particles. The combination of heat generated by the device and chemical reactions from ozone cleaning created a perfect storm for rapid foam breakdown.

As of April 2024, the FDA received over 116,000 Medical Device Reports related to the recall. These reports include 561 suspected deaths linked to the faulty foam.

Affected devices include the DreamStation 1, SystemOne, and multiple CPAP/BiPAP product lines—approximately 5.5 million devices in the U.S. alone.

Philips attempted repairs by replacing PE-PUR foam with silicone foam. However, even some replacement units were later recalled due to separate safety concerns and reprogramming errors, compounding the frustration of users who trusted the company to fix the problem.

This second wave of issues further eroded confidence in the company’s ability to address the crisis effectively.

The $1.1 Billion Settlement: Who Qualifies and What You Can Expect

On April 29, 2024, Philips reached a $1.1 billion agreement to resolve personal injury claims in U.S. federal court. The settlement breaks down into two main components:

• $1.075 billion for personal injury claims covering conditions like cancer, respiratory failure, and organ damage

• $25 million for medical monitoring for users without current symptoms who need ongoing health screenings

Approximately 58,000 people have already filed claims or registered for the settlement. Eligibility requirements include:

• Having used a recalled Philips device

• Typically being under 80 years of age

• Having a diagnosed condition such as cancer or respiratory failure

• Being able to provide medical records

• Ideally, still possessing the recalled device as evidence

Reported injuries in lawsuits span a devastating range. Cancers include lung, kidney, liver, nasal, brain, breast, prostate, stomach, and testicular cancers, as well as leukemia and non-Hodgkin lymphoma.

Respiratory conditions include asthma, pneumonia, and acute respiratory distress syndrome. Organ damage encompasses kidney, liver, and heart disease or failure.

Payments are expected to begin in 2025, pending final court approval by Senior U.S. District Judge Joy Flowers Conti. Philips settled without admitting liability—a standard legal maneuver that protects the company from future claims but offers no acknowledgment of wrongdoing to victims.

A separate $613.3 million economic loss settlement (approved April 2024) covers device reimbursement. This includes an additional $100 return award if you returned your device by August 9, 2024.

Participating in the economic loss settlement does not prevent you from filing a personal injury claim—you can pursue both forms of compensation.

If the settlement is not finalized, bellwether trials (test cases) are scheduled to begin in 2025. These trials could result in higher individual payouts but also carry the risk of no compensation and years of additional litigation.

What You Should Do Right Now If You Used a Philips CPAP

Step 1: Verify if your device is recalled. Check the serial number on the Philips recall website. Serial numbers are typically located on the back or bottom of the device. The recall affects DreamStation 1, SystemOne, and multiple CPAP/BiPAP models manufactured between 2008 and 2021.

Step 2: Do not stop using your CPAP without consulting your doctor first. Untreated sleep apnea carries immediate cardiovascular risks including heart failure, stroke, and dangerous drops in blood oxygen levels during sleep. The risks of stopping therapy abruptly may outweigh the risks of continued use in some cases.

Step 3: Schedule an appointment with your sleep specialist. Discuss transitioning to a non-Philips alternative such as ResMed AirSense 10 or 11, Fisher & Paykel devices, or other brands unaffected by this recall. Your doctor can help you obtain a new prescription and work with your insurance company for coverage.

Step 4: Register your device on the settlement websites. Even if the August 9, 2024 return deadline has passed, you may still qualify for other forms of compensation. Registration keeps you included in future disbursements and communications about the settlement.

Step 5: Preserve your device as evidence. If you’re pursuing a personal injury claim, do not dispose of your machine or return it to Philips without consulting an attorney first. The physical device may serve as vital evidence regarding the state of foam degradation.

Step 6: Document everything. Record dates of use, symptoms experienced, medical diagnoses, and any communications with Philips or your healthcare provider. This documentation strengthens your claim and helps establish a timeline of exposure and health effects.

Step 7: Consult a product liability attorney. If you’ve developed health complications, most firms offer free case reviews and operate on a contingency fee basis—no payment unless a settlement is reached. Attorneys can evaluate your case and guide you through the claims process.

Consider non-CPAP alternatives. If you’re frustrated with traditional CPAP therapy, explore oral appliances like Mandibular Advancement Devices (MADs) or Tongue Retraining Devices (TRDs).

Snoring HQ offers detailed reviews of devices such as SnoreRx, VitalSleep, and Good Morning Snore Solution—non-invasive options with no foam components that offer a different risk profile for managing snoring and mild to moderate sleep apnea.

Frequently Asked Questions

Can I Still Use My Philips CPAP If I Haven’t Had Symptoms?

No—the FDA and Philips recommend discontinuing use of recalled devices immediately. Even without symptoms, you may be inhaling toxic particles or VOCs that cause long-term damage.

The absence of immediate symptoms doesn’t mean you’re not being exposed. Consult your doctor about transitioning to a safe alternative as soon as possible.

How Do I Know If My Health Problems Are Related to the Philips Device?

Only a medical professional can determine causation between device use and health complications. Common symptoms include respiratory issues, chronic headaches, sinus infections, and unexplained organ damage.

If you’ve been diagnosed with cancer or respiratory failure after using a recalled device, document your usage history and consult a product liability attorney who can help establish the connection.

What If I Already Returned My Device to Philips?

You may still be eligible for the economic loss settlement even if you’ve returned your device. For personal injury claims, lack of physical evidence may weaken your case but does not automatically disqualify you.

Medical records and proof of device ownership (receipts, insurance records, prescription documentation) can support your claim. Consult an attorney to evaluate your specific situation.

Are Other CPAP Brands Safe to Use?

ResMed, Fisher & Paykel, DeVilbiss, and other major brands were not involved in this recall. Always verify FDA 510(k) clearance for any medical device before use.

Avoid ozone-based cleaners (SoClean, Lume) for any CPAP device—they can accelerate material degradation regardless of brand. Stick to manufacturer-recommended cleaning methods using mild soap and water.

What Happens to Philips CPAP Users Now?

As of January 2024, Philips stopped selling new CPAP/BiPAP devices in the U.S. under a consent decree with federal authorities. Philips can still service existing machines and provide replacement parts for devices currently in use.

Sales will only resume once the company meets rigorous FDA safety requirements. Current users should transition to alternative brands for long-term reliability.

Final Thoughts: Trust, But Verify

The Philips recall is a stark reminder that even FDA-cleared medical devices can fail—and corporations may prioritize profits over patient safety. You deserve better than a device that puts your health at risk while you sleep.

Whether you’re pursuing legal compensation or exploring safer alternatives, you’re not alone in this fight.

“Medical device recalls remind us that vigilance doesn’t end at FDA approval. Patients and healthcare providers must remain alert to emerging safety signals throughout a product’s lifecycle.” — Dr. Michael Carome, Director of Public Citizen’s Health Research Group

The settlement represents a step toward accountability, but it doesn’t restore the trust that was broken. For millions of people who relied on these devices to breathe safely at night, the betrayal runs deep.

The fact that Philips may have known about the risks years before warning the public makes this more than a product defect—it’s a failure of corporate responsibility.

At Snoring HQ, we’re committed to helping you find non-invasive, effective options that don’t come with hidden risks. Our detailed reviews of oral appliances, nasal devices, and positional aids provide alternatives that give you control over your sleep health without the complexity and potential dangers of traditional CPAP therapy.

Because your sleep and your health matter—and you shouldn’t have to choose between breathing safely and sleeping soundly.